Skip to main content
. 2021 Feb 20;13(4):892. doi: 10.3390/cancers13040892

Figure 1.

Figure 1

Mutations in tumors from 36 patients: (A) number of mutations; (B) BRAF; (C) NRAS; (D) TERT promoter; (E) tumor suppressor genes; (F) key pathways and functional groups.